A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
source: pixabay.com

A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!

Edwin Chapman, who works at the University of Wisconsin-Madison, has been studying neurons for most of his career. He and his team recently made a discovery regarding SYT1-associated neurodevelopmental disorder.…

Continue Reading A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
ANCA Vasculitis Could Be Severe Complication of Lemtrada
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

ANCA Vasculitis Could Be Severe Complication of Lemtrada

According to ANCA Vasculitis News, recent research shows that patients with multiple sclerosis who are being treated with Lemtrada are at greater risk of developing severe ANCA vasculitis. The drug therapy…

Continue Reading ANCA Vasculitis Could Be Severe Complication of Lemtrada
New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica
Science!

New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica

  Technological advancement throughout the world will ultimately lead to new ideas and strategies within the medical realm. As reported by Azo Sensors, a team of Brazilian researchers is already…

Continue Reading New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica
Patients with Multiple Sclerosis Use Robotic Exoskeleton for Movement Improvement
https://pixabay.com/en/technology-robot-human-hand-2025795/

Patients with Multiple Sclerosis Use Robotic Exoskeleton for Movement Improvement

According to WMC5, a research study out of Cleveland, OH, has been testing the impact of robotic exoskeletons on movement for patients with multiple sclerosis. For Kathy Miska, this is…

Continue Reading Patients with Multiple Sclerosis Use Robotic Exoskeleton for Movement Improvement
Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
Pexels / Pixabay

Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

  A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…

Continue Reading Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients
source: pixabay.com

Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients

According to a story from NeurologyLive, patients being treated for autoimmune diseases such as multiple sclerosis (MS) or myasthenia gravis could be at heightened risk of infection with coronavirus because…

Continue Reading Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients
Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action
source: pixabay.com

As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action

According to a story from newsroom.heart.org, one of the most substantial domestic policy achievements of the Obama administration was the passage of the Affordable Care Act (ACA). Since its passage,…

Continue Reading As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action
Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
source: pixabay.com

Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss

According to a story from Medical Xpress, a team of researchers from the medical school at the University of Massachusetts has revealed new information about the nature of neurodegenerative symptoms…

Continue Reading Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
source: pixabay.com

Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients

A New Working Group A team of healthcare professionals from the Institute for Quality and Efficacy in Health Care, the Drug Commission of the German Medical Association, and the Charité…

Continue Reading Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients